Wolf A - Search Results

1

Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.

Lacey LA, Wolf A, O'shea D, Erny S, Ruof J. Lacey LA, et al. Among authors: wolf a. Int J Obes (Lond). 2005 Aug;29(8):975-82. doi: 10.1038/sj.ijo.0802947. Int J Obes (Lond). 2005. PMID: 15852050

2

Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.

Maetzel A, Ruof J, Covington M, Wolf A. Maetzel A, et al. Among authors: wolf a. Pharmacoeconomics. 2003;21(7):501-12. doi: 10.2165/00019053-200321070-00005. Pharmacoeconomics. 2003. PMID: 12696990

3

Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort.

Pendergast K, Wolf A, Sherrill B, Zhou X, Aronne LJ, Caterson I, Finer N, Hauner H, Hill J, Van Gaal L, Coste F, Despres JP. Pendergast K, et al. Among authors: wolf a. Value Health. 2010 Jun-Jul;13(4):402-10. doi: 10.1111/j.1524-4733.2009.00690.x. Epub 2010 Jan 26. Value Health. 2010. PMID: 20113460 Free article.

4

Cost-effectiveness of diabetes education.

Urbanski P, Wolf A, Herman WH. Urbanski P, et al. Among authors: wolf a. J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S6-11. doi: 10.1016/j.jada.2008.01.019. J Am Diet Assoc. 2008. PMID: 18358259 Review.

5

Lifestyle intervention in obese patients with type 2 diabetes: impact of the patient's educational background.

Gurka MJ, Wolf AM, Conaway MR, Crowther JQ, Nadler JL, Bovbjerg VE. Gurka MJ, et al. Obesity (Silver Spring). 2006 Jun;14(6):1085-92. doi: 10.1038/oby.2006.124. Obesity (Silver Spring). 2006. PMID: 16861614 Free article. Clinical Trial.

6

Economic outcomes of the obese patient.

Wolf AM. Wolf AM. Obes Res. 2002 Nov;10 Suppl 1:58S-62S. doi: 10.1038/oby.2002.191. Obes Res. 2002. PMID: 12446860 Free article. Review. No abstract available.

7

Estimating the effect of changes in body mass index on health state preferences.

Hakim Z, Wolf A, Garrison LP. Hakim Z, et al. Among authors: wolf a. Pharmacoeconomics. 2002;20(6):393-404. doi: 10.2165/00019053-200220060-00004. Pharmacoeconomics. 2002. PMID: 12052098

8

Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study.

Wolf AM, Conaway MR, Crowther JQ, Hazen KY, L Nadler J, Oneida B, Bovbjerg VE; Improving Control with Activity and Nutrition (ICAN) Study. Wolf AM, et al. Diabetes Care. 2004 Jul;27(7):1570-6. doi: 10.2337/diacare.27.7.1570. Diabetes Care. 2004. PMID: 15220230 Clinical Trial.

9

Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN).

Wolf AM, Siadaty M, Yaeger B, Conaway MR, Crowther JQ, Nadler JL, Bovbjerg VE. Wolf AM, et al. J Am Diet Assoc. 2007 Aug;107(8):1365-73. doi: 10.1016/j.jada.2007.05.015. J Am Diet Assoc. 2007. PMID: 17659904 Clinical Trial.

10

Impact of lifestyle intervention on lost productivity and disability: improving control with activity and nutrition.

Wolf AM, Siadaty MS, Crowther JQ, Nadler JL, Wagner DL, Cavalieri SL, Elward KS, Bovbjerg VE. Wolf AM, et al. J Occup Environ Med. 2009 Feb;51(2):139-45. doi: 10.1097/JOM.0b013e3181965db5. J Occup Environ Med. 2009. PMID: 19209034 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,364 results

Search Page

Filters